35 results
8-K
EX-3.1
KPRX
Kiora Pharmaceuticals Inc
6 Jun 23
Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering
4:52pm
8-K
EX-3.1
KPRX
Kiora Pharmaceuticals Inc
26 Sep 22
Material Modifications to Rights of Security Holders
6:45am
8-K
EX-3.1
KPRX
Kiora Pharmaceuticals Inc
4 Aug 22
Amendments to Articles of Incorporation or Bylaws
4:36pm
8-K
EX-3.1
KPRX
Kiora Pharmaceuticals Inc
26 Jul 22
Kiora Pharmaceuticals Announces Pricing of $5.2 Million Underwritten Public Offering
4:31pm
8-K
EX-3.1
pdr imd4c
8 Nov 21
EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s
7:32am
8-K
EX-3.2
qgsqa2asim1 jgjku2u
8 Nov 21
EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s
7:32am
8-K
EX-3.1
r3h4ti014a0vtl xow8l
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
8-K
EX-3.1
ywwim a8g6tz
26 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:16pm
8-K
EX-3.1
g567v0qz
29 Aug 19
Material Modifications to Rights of Security Holders
12:45pm
8-K
EX-3.1
fsg9urik
11 Jul 18
Amendments to Articles of Incorporation or Bylaws
4:42pm
8-K
EX-3.1
c4osf
17 Apr 18
EyeGate Announces Completion of $11.25 Million Public Offering
12:00am
8-K
EX-3.1
p0r7c3bpkfhm14868
13 Apr 18
EyeGate Announces $11.25 Million Public Offering
12:00am
8-K
EX-3.1
cv7nkrh8e6l2at
14 Jun 17
EyeGate Announces Completion of $10.0 Million Public Offering
12:00am
8-K
EX-3.1
ybtexgiaul7uughf46
9 Jun 17
EyeGate Announces $10.0 Million Public Offering
12:00am
8-K
EX-3.1
5nku471g7hcspnm8gb0
30 Jun 16
EyeGate Announces Completion of $3.77 Million Registered Direct Offering
12:00am